Impact of obstructive sleep apnea on clinical outcomes in patients hospitalized with COVID-19.

S F J VonckenT M H FeronS A J S LavenU KaracaK BeerhorstP KlarenbeekJ M J A A StraetmansG J de VriesA A B Kolfoort-OtteMartijn D de Kruif

Published in: Sleep & breathing = Schlaf & Atmung (2021)

The prevalence of OSA did not differ between patients with or without COVID-19, but mortality and hospital length of stay were increased in patients with OSA and comorbid COVID-19. Hence, OSA should be included in COVID-19 risk factor analyses, Clinicians should be aware of the association and the mechanism should be further explored.

Keyphrases

coronavirus disease
obstructive sleep apnea
sars cov
positive airway pressure
risk factors
end stage renal disease
chronic kidney disease
healthcare
newly diagnosed
ejection fraction
palliative care
cardiovascular events
type diabetes
prognostic factors
cardiovascular disease
coronary artery disease
adverse drug